Cantor Fitzgerald Weighs in on Centene FY2025 Earnings

Centene Co. (NYSE:CNC - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Centene in a research report issued to clients and investors on Tuesday, January 21st. Cantor Fitzgerald analyst S. James forecasts that the company will post earnings of $7.27 per share for the year. Cantor Fitzgerald has a "Overweight" rating and a $90.00 price objective on the stock. The consensus estimate for Centene's current full-year earnings is $6.81 per share.

Several other equities research analysts also recently commented on the company. JPMorgan Chase & Co. reiterated an "overweight" rating and issued a $75.00 price objective (down from $80.00) on shares of Centene in a report on Tuesday, December 17th. StockNews.com cut shares of Centene from a "strong-buy" rating to a "buy" rating in a report on Monday, October 28th. Oppenheimer dropped their target price on shares of Centene from $95.00 to $85.00 and set an "outperform" rating on the stock in a report on Friday, December 13th. Stephens lowered their price target on Centene from $75.00 to $73.00 and set an "equal weight" rating on the stock in a report on Friday, December 13th. Finally, Barclays lifted their price objective on Centene from $91.00 to $93.00 and gave the stock an "overweight" rating in a report on Friday, December 13th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $80.92.

Centene Stock Down 0.0 %

CNC traded down $0.03 during trading on Wednesday, hitting $63.63. 1,880,971 shares of the company's stock traded hands, compared to its average volume of 4,114,831. The stock has a market capitalization of $32.12 billion, a price-to-earnings ratio of 11.07, a PEG ratio of 0.83 and a beta of 0.45. The company's 50 day simple moving average is $60.25 and its two-hundred day simple moving average is $67.28. Centene has a 12-month low of $55.03 and a 12-month high of $81.42. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64.

Insiders Place Their Bets

In other Centene news, Director Thomas Greco bought 17,000 shares of Centene stock in a transaction dated Wednesday, December 18th. The shares were purchased at an average cost of $59.75 per share, for a total transaction of $1,015,750.00. Following the acquisition, the director now directly owns 19,309 shares in the company, valued at approximately $1,153,712.75. This represents a 736.25 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Sarah London purchased 4,117 shares of the company's stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $60.80 per share, with a total value of $250,313.60. Following the transaction, the chief executive officer now owns 667,229 shares of the company's stock, valued at $40,567,523.20. This represents a 0.62 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired 45,010 shares of company stock worth $2,660,276 in the last three months. 0.29% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Park Place Capital Corp boosted its stake in shares of Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company's stock valued at $29,000 after purchasing an additional 357 shares during the period. Private Trust Co. NA grew its stake in Centene by 75.3% in the third quarter. Private Trust Co. NA now owns 773 shares of the company's stock worth $58,000 after purchasing an additional 332 shares in the last quarter. True Wealth Design LLC bought a new stake in shares of Centene in the third quarter valued at about $66,000. EverSource Wealth Advisors LLC lifted its position in shares of Centene by 104.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company's stock worth $82,000 after purchasing an additional 630 shares during the period. Finally, Venturi Wealth Management LLC boosted its stake in shares of Centene by 77.3% during the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company's stock valued at $88,000 after purchasing an additional 507 shares in the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.